155 related articles for article (PubMed ID: 1325885)
1. Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis.
Perich RB; Jackson B; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):353-7. PubMed ID: 1325885
[TBL] [Abstract][Full Text] [Related]
2. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Perich RB; Jackson B; Johnston CI
Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
[TBL] [Abstract][Full Text] [Related]
3. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
[TBL] [Abstract][Full Text] [Related]
4. Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins.
Bevilacqua M; Vago T; Rogolino A; Conci F; Santoli E; Norbiato G
J Cardiovasc Pharmacol; 1996 Oct; 28(4):494-9. PubMed ID: 8891872
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
7. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.
Jackson B; Cubela RB; Sakaguchi K; Johnston CI
Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.
Fabris B; Yamada H; Cubela R; Jackson B; Mendelsohn FA; Johnston CI
Br J Pharmacol; 1990 Jul; 100(3):651-5. PubMed ID: 2167741
[TBL] [Abstract][Full Text] [Related]
9. Characterization of angiotensin converting enzyme from rat tissue by radio-inhibitor binding studies.
Jackson B; Cubela R; Johnston CI
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):681-9. PubMed ID: 3026703
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
Williams TA; Barnes K; Kenny AJ; Turner AJ; Hooper NM
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):875-81. PubMed ID: 1335236
[TBL] [Abstract][Full Text] [Related]
11. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
[TBL] [Abstract][Full Text] [Related]
12. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Chappell MC; Pirro NT; Sykes A; Ferrario CM
Hypertension; 1998 Jan; 31(1 Pt 2):362-7. PubMed ID: 9453329
[TBL] [Abstract][Full Text] [Related]
14. Evidence for two binding sites on membrane-bound angiotensin-converting enzymes (ACE) for exogenous inhibitors except in testis.
Brée F; Hamon G; Tillement JP
Life Sci; 1992; 51(10):787-94. PubMed ID: 1325020
[TBL] [Abstract][Full Text] [Related]
15. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay.
Jackson B; Cubela R; Johnston CI
Biochem Pharmacol; 1987 Apr; 36(8):1357-60. PubMed ID: 3036166
[TBL] [Abstract][Full Text] [Related]
16. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
17. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
[TBL] [Abstract][Full Text] [Related]
18. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
[TBL] [Abstract][Full Text] [Related]
19. Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation.
Daud AI; Bumpus FM; Husain A
Endocrinology; 1990 Jun; 126(6):2927-35. PubMed ID: 2161740
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic data reveal the heterogeneity of angiotensin-converting enzyme according to its source (lung versus heart).
Vago T; Bevilacqua M; Conci F; Rogolino A; Norbiato G
Am J Cardiol; 1995 Jun; 75(18):13F-17F. PubMed ID: 7778528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
